Zimbabwe Halts $367 Million US Health Deal Over Data Concerns

Harare, Zimbabwe – Negotiations between Zimbabwe and the United States for a $367 million five-year health funding agreement have collapsed, with Zimbabwe citing concerns over data sharing, fairness, and national sovereignty. The U.S. Has announced it will begin winding down its health assistance programs in the country as a result.

Data Sharing and Sovereignty at Issue

The proposed agreement, which would have been the largest health investment in Zimbabwe by any international partner, was intended to support key health programs including HIV/AIDS treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness . However, Zimbabwean officials determined the conditions attached to the funding were unacceptable.

According to Nick Mangwana, Zimbabwe’s government spokesperson, the U.S. Proposal required “comprehensive access to Zimbabwe’s sensitive health data, including virus samples and epidemiological information from our citizens” . He further stated that the U.S. Was not offering reciprocal sharing of its own epidemiological data.

“our nation would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our people should a future health crisis emerge,” Mangwana explained .

U.S. Response and Existing Aid

U.S. Ambassador to Zimbabwe, Pamela Tremont, expressed regret over the outcome, stating, “We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe” . She added that Zimbabwe indicated it was prepared to continue its HIV response independently.

The U.S. Has provided nearly $2 billion in health assistance to Zimbabwe since 2006, which the U.S. Embassy says has been instrumental in the country’s progress towards United Nations HIV treatment targets . The future of programs like the rollout of lenacapavir, a long-acting HIV prevention drug supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund, is now uncertain.

Shift in U.S. Health Funding Strategy

The collapse of the agreement comes amid a broader shift in U.S. Health funding strategies under recent administrations. The U.S. Has pursued bilateral “America First” health funding agreements, replacing arrangements previously coordinated through the U.S. Agency for International Development . Agreements worth over $18 billion have been signed with 16 African countries, with recipient countries contributing approximately $7.1 billion.

However, this new model has faced scrutiny, including a High Court suspension of implementation in Kenya due to data safety concerns . Zimbabwe has likewise voiced concerns that this bilateral approach departs from the multilateral frameworks of the World Health Organization (WHO).

Concerns from Public Health Officials

Zimbabwe’s College of Public Health Physicians has urged continued negotiations, warning that an abrupt end to U.S. Funding could jeopardize critical components of the country’s public health system, potentially leading to treatment interruptions, increased transmission rates, and drug resistance .